way of stimulation, it is possible to check the calcemia variations; while with the tests using the latter one, it is possible to follow the variations of phosphatemia and tubular reabsorption of phosphorus.
The hypocalcemia is generally determined either with infusion of calciumchelating agents or providing a low phosphorus intake, in association with agents to prevent its intestinal absorption.
The sodium versenate (Disodium-ethylendiamin-tetracetate) is universally used as a calcium-chelating agent because of its low toxicity, of its marked activity in producing hypocalcemia and in consideration of its rapid elimination through the kidney (Kaiser and Pensold, 1959; Albach, 1960) .
Versenate is given intravenously, diluted in a 5% glucose in water solution over a 2-hour period. The calcium serum level is evaluated before, and at different intervals of time from the moment the intravenons injection is over.
As far as the dosage of versenate is concerned, there is disagreement among the various authors. The amonnt of 70mg/kg recommended by Kaiser and Pensold (1959) is believed to be too high according to Klotz and Clement (1961) who feel that such a dosage may induce, even in normal subjects, a decreasing of the calcemia similar to that induced in hypoparathyroid patients. According to Albach (1960) , the quantity of versenate and glucose solution to be given should be calculated, in each single case, in proportion to the volume of the circulating blood and to the total quantity of calcium ion.
Regarding the interpretation of the results, Kaiser and Pensold (1959) and Albach (1960) believe that the evaluation of the calcemia after 12 hrs. is a certain index of the grade of the function of the parathyroid. Klotz and Clement (1961) , on the other hand, think that the serum level of the calcium obtained 1hr. after the infusion is more important; according to these two authors, a value lower than 92% of the initial figure stands for a hypofunction of the parathyroid.
The present observation, performed through the original technique by Kaiser and Pensold (1959) , allow to consider as significant the entire proceeding of the calcemic curve during the Kaiser-Pensold test. In Figure 1 , where the results in 2 hypoparathyroid and 1 hyperparathyroid case compared with the results in 6 normal controls, it is observed that the entire calcemic curve in the hypoparathyroid patient is definitely lower than that of the controls. Of a particularly remarkable interest is the calcemic value of 7.4mg observed at the end of the test in this case. Such an observation makes it possible to consider the parathyroid function in the patient as seriously impaired. According to Copp's experiments in parathyroidectomized animals (Copp, 1957) , the rise of the This rise would depend mainly on the exchangeable calcium available in bone and on the bone blood-flow (Copp, 1957) .
Checking the calcemia during the Kaiser-Pensold test seems to be of a great help in the hyperfunction of the parathyroid too. In a female patient ( Fig. 1) not only a lesser decrease of the calcemia compared to the controls, but also a more rapid calcemia recovery were observed to the point that after 12hrs. the calcemia was sensibly above normal.
The low-calcium diet associated with agents inhibiting the intestinal reabsorption of this electrolyte has been less used in diagnosing parathyroid disorders.
However, from the data by Smith et al.(1960) , it is apparent that such a diet, associated to sodium phytate which is decreasing the calcium intestinal absorption (Mellanby), may cause in hypoparathyroidism a fall on the blood level of this electrolyte in comparison with normal controls.
The stimulation of the parathyroid through the increase of the inorganic phosphorus level is obtained by supplying intravenously, or preferably per os, a load of inorganic phosphorus salts. The technique of performance of this test is not well established, but varies according to different authors (Crawford et al., 1950; Harrison and Harrison, 1941; Klein and Gow, 1953; Harrison and Klein, 1953) .
The authors usually give a subject kept on a constant intake of calcium (200 mg per day) and phosphorus (700mg per day), a progressive load of this latter electrolyte as a solution of monobasic potassium phosphate and dibasic sodium phosphate which, after 6 days from the beginning of the test, reaches the maximum figure of 2g per day.
Whatever technique is used to accomplish a phosphorus overload, the various results agree, in that they point out, in the hypofunction of the parathyroid, the following factors: 1) Hyperphosphatemia not depending on the variations of the calcemia, 2) A persistently high figure of the tubular reabsorption and glomerular normal controls. This is clearly shown in Figure 2 where are reported the results in a case of hypoparathyroidism and in a normal control, who have been subjected to a phosphorus overload per os. It is believed that the use of such a test in subjects affected by possible hyperparathyroidism is dangerous because such patient have an elevated calciuria and they are, therefore, predisposed to a precipitation of calcium salts in the urinary tract.
Also, the techniques of the parathyroid inhibition through a low-phosphorus diet, used by several investigators, are remarkably different because 1) of the calcium and phosphorus contained in the diet, 2) of the duration of the test, 3) of the different time in checking the results, and 4) of the diet of substances pre-venting the phosphorus intestinal absorption (Chambers et al., 1956; Pronove et al., 1961) . The most studied parameters, during the performance of the test, are:
phosphatemia, calcemia, calciuria and the phosphorus tubular reabsorption; the variation of the phosphaturia has been shown to be of little value.
To the controls a daily diet containing 500mg phosphorus and 200mg calcium is supplied; the phosphorus absorption is reduced by 1.5g of alminum hydroxide daily. The total calciuria and phosphaturia are checked daily and the calcemia, phosphatemia and the TRP/GFP ratio every other day. The phosphorus deprivation test is used only to diagnose hyperparathyroidism; in this ailment, it is found that: 1) Phosphatemia, which in controls decrease to levels lower than normal, does not show a significant variation in hyperparathyroid patients with low phosphatemia, in those having a normal phosphatemia, decreases insteads of definitely pathological levels (Chambers et al., 1956) ; 2) Calcemia, which is significantly modified in normal subjects, is slightly increased in hyperparathyroidism (Chambers et al., 1956; Pronove et al., 1961) ; 3) The TRP/GFP relation increases progressively in hyperparathyroid patients up to the end of the test, as opposed to normal cases in which the increase is limited to the first days of the test. According to Chambers et al., (1956) , the particular difference between normal and hyperparathyroidic subjects would be most evident from the 3rd to the 5th day from the beginning of the test. 4) Calciuria increases more evidently (above 250 mg/day according to Pronove et al., 1961) in hyperparathyroidism than in normal condition.
What is said above agrees fully with some of the data reported in Figure 4 where the values of calcemia, phosphatemia and TRP/GFP ratio in a hyperparathyroid patient are compared with a normal subject during the phosphorus deprivation test. To complement the data shown in Figure 4 , it may be added that, according to the observations of Pronove and co-workers (1961), the calciuria in this same patient has been fluctuating, during the performance of the test, around values of 250mg per day, while in the controls it has never exceeded the figure of 170mg per day. The values obtained in the present cases are different from the data recorded in the literature only because of the action of the calcemia, which, in fact, underwent a limited decrease in the first days of the test; at the present status of the present investigation, the reason for such a reaction is unknown.
III.
Calcium turnover determination tests It is performed supplying a strontium salt or a radioactive isotope of it (Harrison et al., 1960; Rich et al., 1961) or radioactive isotopes of calcium (Milhaud and Aubert, 1958; Doering, 1963 (Doering, 1963; , because the former has a half life remarkably longer than the latter (153 days instead of 4.7 days) and avoids, therefore, the demand for a continuous supply; on the other hand, the dose of Ca45 given by us is not significant and, anyway, it is definitely lower that the maximum dose permitted (Fossati et al., 1956 ).
In Table 1 , it was reported that the results of the calcium turnover obtained Table 1 . Calcium turnover studied through Ca45 intravenous infusion in 2 normal subjects, in 2 with hypoparathyroid and in 1 with hyperparathyroid function. The analysis of the data reported in this table and a comparison to the data reported in the literature, leads to the following remarks: (1) The figures of the present study are comparable to those found by most authors (Bauer et al. 1958; Heaney and Whedon, 1958; Dow et al., 1960; Bluhm et al., 1960) and are different only from the data by Milhaud and Aubert (1958) , Milhaud et al. (1959) , and by Oeff et al. (1962) , particularly as far as the exchangeable calcium pool and the bone in normal subjects. (3) The only phenomenon observed constantly is the decrease of the exchangeable calcium pool and of the bone fixation rate in hypoparathyroid patients in comparison to normal controls. According to these findings and to the fact that the calcium turnover is abnormal in other different diseases (Doering, 1963; Milhaud et al., 1959; Oeff et al., 1962) , it is believed that the calcium turnover determination test, at least in this stage of the problem, is of little importance in diagnosing the parathyroid disorder. 
